Home > Healthcare > Medical Devices > Therapeutic Devices > Ophthalmic Eye Dropper Market
Ophthalmic Eye Dropper Market Trends
- Report ID: GMI8332
- Published Date: Jul 2024
- Report Format: PDF
Ophthalmic Eye Dropper Market Trends
- The ophthalmic eye dropper industry is witnessing substantial growth, fueled by a rise in eye-related conditions such as glaucoma, dry eye syndrome, and infections, particularly prevalent among the elderly population.
- Market expansion is further bolstered by advancements in drug delivery systems and the creation of preservative-free formulations. The increasing prevalence of diabetes, which often leads to diabetic retinopathy and other ocular complications, is driving demand for sophisticated ophthalmic solutions.
- Further, technological progress in ophthalmic formulations, alongside the integration of user-friendly features in droppers, such as easy-to-squeeze bottles and precise drop dispensers, are improving patient compliance and adherence to prescribed treatments.
Frequently Asked Questions (FAQ) :
Ophthalmic eye dropper industry size was worth USD 14.5 billion in 2023 and will expand at a 6.7% CAGR between 2024 and 2032, driven by the increasing prevalence of eye disorders.
The preserved multi-dose eye dropper segment achieved USD 7.1 billion in 2023 due to the convenience and cost-effectiveness offered by preserved multi-dose eye droppers for chronic eye conditions.
U.S. ophthalmic eye dropper industry will reach USD 8 billion by 2032, owing to the nation's advanced healthcare infrastructure and high prevalence of eye disorders.
Key players operating in the ophthalmic eye dropper industry are AbbVie Inc., Alcon Inc., AdvaCare Pharma, Bausch Health Companies Inc., Domp
Ophthalmic Eye Dropper Market Scope
×
Get a free sample of
Ophthalmic Eye Dropper Market
Inquiry Before Buying
Get special pricing options on this report
Request Sectional Data
Over 70% of our clients customize reports to fit their needs. Please tell us how you would like to customize yours
below